Shares of CGI Inc (TSE:GIB.A – Get Free Report) (NYSE:GIB) have earned an average recommendation of “Buy” from the eleven research firms that are currently covering the stock, MarketBeat Ratings reports. Eleven research analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is C$169.83.
Several analysts have commented on the stock. CIBC upgraded shares of CGI from a “neutral” rating to an “outperform” rating and raised their price objective for the stock from C$155.00 to C$178.00 in a report on Tuesday, October 15th. Raymond James raised their target price on CGI from C$171.00 to C$180.00 in a research note on Thursday, November 7th. Royal Bank of Canada lifted their price target on CGI from C$170.00 to C$178.00 in a research report on Thursday, November 7th. Finally, Canaccord Genuity Group increased their price objective on CGI from C$170.00 to C$175.00 in a report on Thursday, November 7th.
Get Our Latest Analysis on CGI
CGI Trading Up 0.3 %
CGI Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 20th will be issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.37%. The ex-dividend date is Wednesday, November 20th.
About CGI
CGI Inc, together with its subsidiaries, provides information technology (IT) and business process services in Canada, Northern Europe, France, the United States, the United Kingdom, Europe, and the Asia Pacific. Its services include the management of IT and business outsourcing, systems integration and consulting, and software solutions selling activities.
See Also
- Five stocks we like better than CGI
- Technology Stocks Explained: Here’s What to Know About Tech
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Using the MarketBeat Dividend Yield Calculator
- Texas Instruments: The Old-School Tech Titan Still Delivering
- 3 Warren Buffett Stocks to Buy Now
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for CGI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CGI and related companies with MarketBeat.com's FREE daily email newsletter.